Involved-site image-guided intensity modulated versus 3d conformal radiation therapy in early stage supradiaphragmatic Hodgkin lymphoma

International Journal of Radiation Oncology Biology Physics

Volumn 89, Issue 2, 2014, Pages 370-375

  Filippi, Andrea Riccardo ^a   Ciammella, Patrizia ^b   Piva, Cristina ^a   Ragona, Riccardo ^a   Botto, Barbara ^c   Gavarotti, Paolo ^d   Merli, Francesco ^b   Vitolo, Umberto ^c   Iotti, Cinzia ^b   Ricardi, Umberto ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b S MARIA NUOVA HOSPITAL   (Italy)

^c CITTÀ DELLA SALUTE E DELLA SCIENZA HOSPITAL   (Italy)

^d UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMORADIOTHERAPY; CHEMOTHERAPY; DISEASES; HIGH ENERGY PHYSICS; ONCOLOGY; PATIENT MONITORING; TOXICITY;

3D CONFORMAL RADIATION THERAPY; COMPLETE RESPONSE; DELIVERY TECHNIQUES; DOSE DISTRIBUTIONS; INTENSITY MODULATED RADIATION THERAPY; INTENSITY-MODULATED; METHODS AND MATERIALS; TOTAL RADIATION DOSE;

RADIOTHERAPY;

BLEOMYCIN; DACARBAZINE; DOXORUBICIN; VINBLASTINE;

ACUTE TOXICITY; ADOLESCENT; ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL EFFECTIVENESS; COMPARATIVE EFFECTIVENESS; COMPUTER ASSISTED RADIOTHERAPY; EARLY CANCER; ERYTHEMA; FEMALE; FOLLOW UP; HODGKIN DISEASE; HUMAN; IMAGE GUIDED RADIOTHERAPY; INTENSITY MODULATED RADIATION THERAPY; INTERMETHOD COMPARISON; INVOLVED SITE IMAGE GUIDED INTENSITY MODULATED RADIOTHERAPY; INVOLVED SITE THREE DIMENSIONAL CONFORMAL RADIOTHERAPY; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM CANCER; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; OUTCOME ASSESSMENT; POST TREATMENT SURVIVAL; PRIORITY JOURNAL; RADIATION DERMATITIS; RADIATION DOSE; RADIATION INJURY; RADIATION PNEUMONIA; RECURRENCE FREE SURVIVAL; RETROSPECTIVE STUDY; SURVIVAL RATE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; COMBINED MODALITY THERAPY; DACARBAZINE; DISEASE-FREE SURVIVAL; DOXORUBICIN; FEMALE; HODGKIN DISEASE; HUMANS; MALE; MEDIASTINAL NEOPLASMS; MIDDLE AGED; RADIOTHERAPY, CONFORMAL; RADIOTHERAPY, IMAGE-GUIDED; RADIOTHERAPY, INTENSITY-MODULATED; RETROSPECTIVE STUDIES; TUMOR BURDEN; VINBLASTINE; YOUNG ADULT;

EID: 84899911187     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2014.01.041     Document Type: Article

References (26)

1. G. Bonadonna, V. Bonfante, and S. Viviani et al. ABVD plus subtotal nodal versus involved-field radiotherapy in early-stage Hodgkin's disease: long-term results J Clin Oncol 22 2004 2835 2841
2. A. Engert, A. Plutschow, and H.T. Eich et al. Reducing treatment intensity in patients with early stage Hodgkin's lymphoma N Engl J Med 363 2010 640 652
3. H.T. Eich, V. Diehl, and H. Görgen et al. Intensified chemotherapy and dose-reduced involved-field radiotherapy in patients with early unfavorable Hodgkin's lymphoma: Final analysis of the German Hodgkin Study Group HD11 trial J Clin Oncol 28 2010 4199 4206
4. R.M. Meyer, M.K. Gospodarowicz, and J.M. Connors et al. ABVD alone versus radiation-based therapy in limited-stage Hodgkin's lymphoma N Engl J Med 366 2012 399 408
5. A.K. Ng, and P.M. Mauch Late effects of Hodgkin's disease and its treatment Cancer J 15 2009 164 168
6. A.J. Swerdlow, C.D. Higgins, and P. Smith et al. Myocardial infarction mortality risk after treatment for Hodgkin disease: A collaborative British cohort study J Natl Cancer Inst 99 2007 206 214
7. L.B. Travis, D. Hill, and G.M. Dores et al. Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma J Natl Cancer Inst 97 2005 1428 1437
8. M.L. De Bruin, J. Sparidans, and M.B. van't Veer et al. Breast cancer risk in female survivors of Hodgkin's lymphoma: Lower risk after smaller radiation volumes J Clin Oncol 27 2009 4239 4246
9. T. Girinsky, R. Van Der Maazen, and L. Specht et al. Involved-node radiotherapy (INRT) in patients with early Hodgkin lymphoma: Concepts and guidelines Radiother Oncol 79 2006 270 277
10. M.V. Maraldo, M.C. Aznar, and I.R. Vogelius et al. Involved node radiation therapy: An effective alternative in early stage Hodgkin lymphoma Int J Radiat Oncol Biol Phys 85 2013 1057 1065
11. J. Yahalom, and P. Mauch The involved field is back: Issues in delineating the radiation field in Hodgkin's disease Ann Oncol 13 suppl 1 2002 79 83
12. L. Specht, J. Yahalom, and T. Illidge et al. Modern radiation therapy for Hodgkin's lymphoma: fields and dose guidelines from the International lymphoma Radiation Oncology Group (ILROG) Int J Radiat Oncol Biol Phys 2013 Jun 18 [Epub ahead of print]. doi: 10.1016/j.ijrobp.2013.05.005
13. K.A. Goodman, S. Toner, and M. Hunt et al. Intensity modulated radiotherapy for lymphoma involving the mediastinum Int J Radiat Oncol Biol Phys 62 2005 198 206
14. T. Girinsky, C. Pichenot, and A. Beaudre et al. Is intensity modulated radiotherapy better than conventional radiation treatment and three-dimensional conformal radiotherapy for mediastinal masses in patients with Hodgkin's disease, and is there a role for beam orientation optimization and dose constraints assigned to virtual volumes? Int J Radiat Oncol Biol Phys 64 2006 218 226
15. D.C. Weber, N. Peguret, and G. Dipasquale et al. Involved-node and Involved-field volumetric modulated arc vs. fixed beam intensity-modulated radiotherapy for female patients with early-stage supra-diaphragmatic Hodgkin lymphoma: A comparative planning study Int J Radiat Oncol Biol Phys 75 2009 1578 1586
16. A. Paumier, M. Ghalibafian, and J. Gilmore et al. Dosimetric benefits of intensity modulated radiotherapy combined with deep inspiration breath-hold technique in patients with mediastinal Hodgkin's lymphoma Int J Radiat Oncol Biol Phys 82 2011 1522 1527
17. J. Koeck, Y. Abo-Madyan, and F. Lohr et al. Radiotherapy for early mediastinal Hodgkin lymphoma according to German Hodgkin Study Group (GHSG): The roles of intensity modulated radiotherapy and involved-node radiotherapy Int J Radiat Oncol Biol Phys 83 2012 268 276
18. C. Fiandra, A.R. Filippi, and P. Catuzzo et al. Different IMRT solutions vs. 3D-Conformal Radiotherapy in early stage Hodgkin's lymphoma: Dosimetric comparison and clinical considerations Radiat Oncol 7 2011 186
19. V. De Sanctis, C. Bolzan, and M. D'Arienzo et al. Intensity modulated radiotherapy in early stage Hodgkin lymphoma patients: Is it better than three dimensional conformal radiotherapy? Radiat Oncol 7 2012 Aug 2 129
20. A.R. Filippi, R. Ragona, and M. Fusella et al. Changes in breast cancer risk associated with different volumes, doses and techniques in female Hodgkin's lymphoma patients treated with supra-diaphragmatic radiotherapy Pract Radiat Oncol 3 2013 216 222
21. D.C. Weber, S. Johanson, and N. Peguret et al. Predicted risk of radiation-induced cancers after involved field and involved node radiotherapy with or without intensity modulation for early-stage Hodgkin's lymphoma in female patients Int J Radiat Oncol Biol Phys 81 2011 490 497
22. M.V. Maraldo, N.P. Brodin, and M.C. Aznar et al. Estimated risk of cardiovascular disease and secondary cancers with modern highly conformal radiotherapy for early stage mediastinal Hodgkin's lymphoma Ann Oncol 24 2013 2113 2118
23. L. Cella, M. Conson, and M.C. Pressello et al. Hodgkin's lymphoma emerging radiation treatment techniques: Trade-off between late radiation-induced toxicities and secondary malignant neoplasms Radiat Oncol 8 2013 Jan 30 22
24. B.A. Campbell, N. Voss, and T. Pickles et al. Involved-nodal radiation therapy as a component of combination therapy for limited-stage Hodgkin's lymphoma: A question of field size J Clin Oncol 26 2008 5170 5174
25. A. Paumier, M. Ghalibafian, and A. Beaudre et al. Involved-node radiotherapy and modern radiation treatment techniques in patients with Hodgkin lymphoma Int J Radiat Oncol Biol Phys 80 2011 199 205
26. N.N. Lu, Y.X. Li, and R.Y. Wu et al. Dosimetric and clinical outcomes of involved-field intensity modulated radiotherapy after chemotherapy for early stage Hodgkin's lymphoma with mediastinal involvement Int J Radiat Oncol Biol Phys 84 2012 210 216